Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the page content with an error screen. This prevents viewing details such as study status, locations, contacts, and related information.SummaryDifference18%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a note for NIH grant/contract funding in 2018 and updated the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.6.5 is now displayed, replacing v3.6.4 on the page. This represents a minor version update to the page.SummaryDifference0.1%

- Check66 days agoChange DetectedA new publication citation is added to Publications for a 2025 Allergy study on dupilumab in pediatric peanut allergy, and the revision is updated to v3.6.4.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page’s Revision label was updated from v3.6.2 to v3.6.3, indicating a newer page version. This update is a minor metadata change and does not modify the study details or visible content.SummaryDifference0.1%

- Check95 days agoChange DetectedThe footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the site’s underlying version without altering the page's visible content.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.